GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Conexeu Sciences Inc. Common Stock CNXU · USD

US listing · 🇺🇸 United States

Compare

2.33

+3.10%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$3.9m

FY2024FY2025

Free cash flow

−$1.7m

FY2024FY2025

Shareholders' equity

$7.4m

FY2024FY2025

Income statement

Fiscal years

FY2025FY2024
Research and development$478,169$280,081
Operating income−$4.0m−$643,042
Net income−$3.9m−$471,867
Diluted earnings per share-0.19-0.02

Balance sheet

At each fiscal year end

FY2025FY2024
Total assets$7.7m$533,940
Total liabilities$336,018$438,976
Debt—$98,117
Shareholders' equity$7.4m$94,964
Shares outstanding21m27m

Cash flow

Fiscal years

FY2025FY2024
Cash from operations−$1.7m−$225,439
Capital spending−$18,668—
Free cash flow−$1.7m−$225,439

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025
Operating income−$7.7m−$2.4m−$1.7m−$1.9m−$1.3m−$456,055−$332,721
Net income−$7.7m−$2.3m−$1.7m−$1.9m−$1.3m−$458,050−$290,064
Diluted earnings per share-0.28-0.08-0.06-0.09-0.06-0.02-0.01
Cash from operations−$6.0m−$1.0m−$1.0m————
Total assets$7.2m$8.2m$7.7m$7.7m———
Shareholders' equity$5.9m$7.2m$6.8m$7.4m———

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.